NCT00920439View on ClinicalTrials.gov

Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 1, 2009

Primary Completion Date

August 3, 2009

Study Completion Date

August 3, 2009

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

PoliorixTM

Single dose, intramuscular administration.

Trial Locations (1)

543002

GSK Investigational Site, Wuzhou

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY